Aurora Cannabis Inc (NYSE:ACB) has been assigned a consensus recommendation of “Buy” from the ten research firms that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $10.04.
Several equities research analysts have recently commented on ACB shares. Cowen started coverage on Aurora Cannabis in a research note on Tuesday, March 5th. They issued an “outperform” rating for the company. Seaport Global Securities started coverage on Aurora Cannabis in a research note on Thursday, February 21st. They issued a “neutral” rating for the company. ValuEngine upgraded Aurora Cannabis from a “hold” rating to a “buy” rating in a research note on Tuesday, March 19th. TheStreet lowered Aurora Cannabis from a “c” rating to a “d+” rating in a research note on Monday, February 25th. Finally, Zacks Investment Research upgraded Aurora Cannabis from a “sell” rating to a “hold” rating in a research note on Monday, May 20th.
NYSE:ACB opened at $7.75 on Thursday. The company has a quick ratio of 1.98, a current ratio of 2.37 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $7.87 billion, a PE ratio of 64.58 and a beta of 2.78. Aurora Cannabis has a one year low of $4.05 and a one year high of $12.52.
A number of institutional investors have recently modified their holdings of ACB. Moisand Fitzgerald Tamayo LLC bought a new position in Aurora Cannabis in the 1st quarter worth $25,000. Carroll Financial Associates Inc. bought a new position in Aurora Cannabis in the 1st quarter worth $27,000. Financial Management Professionals Inc. boosted its holdings in Aurora Cannabis by 586.3% in the 1st quarter. Financial Management Professionals Inc. now owns 3,061 shares of the company’s stock worth $28,000 after buying an additional 2,615 shares during the period. Advisory Services Network LLC bought a new position in Aurora Cannabis in the 4th quarter worth $29,000. Finally, Burt Wealth Advisors boosted its holdings in Aurora Cannabis by 1,033.3% in the 1st quarter. Burt Wealth Advisors now owns 3,400 shares of the company’s stock worth $31,000 after buying an additional 3,100 shares during the period. 9.02% of the stock is owned by institutional investors.
About Aurora Cannabis
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Recommended Story: Why is the ex-dividend date different from the record date?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.